2m 2m 2m 2m 2m 2m 2m
Reviva Pharm (RVPH)
OTC
$0.35-$0.24 (-40.98%)
Price as of May 13, 2026 7:59 PM EDT- $4.3MMarket Cap
- -93.09%1-Year Change
- BiotechnologyIndustry
Reviva Pharm (RVPH)
$0.35-$0.24 (-40.98%)
RVPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.59 | ||
Change | -$0.03 (-4.35%) | ||
Open | $0.58 | ||
High | $0.62 | ||
Low | $0.58 | ||
Previous Close | $0.62 | ||
Volume | 36,873 | ||
30-Day Average Volume | 60,261 | ||
1-Week Change | -5.87% | ||
1-Month Change | -13.29% | ||
1-Year Change | -93.09% | ||
3-Year Change | -99.41% | ||
5-Year Change | -99.32% | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $23.6M | ||
Market Cap | $4.3M | ||
Enterprise Value | -$17.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.2M | ||
Free Cash Flow | -$3.8M | ||
EBIT | -$3.2M | ||
EBITDA | -$3.2M | ||
Net Working Capital | $17.4M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 03/09/2026 | ||